Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Brian A Ference"'
Autor:
Natalie Koh, Brian A Ference, Stephen J Nicholls, Ann Marie Navar, Derek P Chew, Karam Kostner, Ben He, Hung Fat Tse, Jamshed Dalal, Anwar Santoso, Junya Ako, Hayato Tada, Jin Joo Park, Mei Lin Ong, Eric Lim, Tavin Subramaniam, Yi-Heng Li, Arintaya Phrommintikul, SS Iyengar, Saumitra Ray, Kyung Woo Park, Hong Chang Tan, Narathip Chunhamaneewat, Khung Keong Yeo, Jack Wei Chieh Tan
Publikováno v:
European Cardiology Review, Vol 16, Iss , Pp - (2021)
The prevalence of dyslipidaemia has been increasing in the Asia-Pacific region and this is attributed to dietary changes and decreasing physical activity. While there has been substantial progress in dyslipidaemia therapy, its management in the regio
Externí odkaz:
https://doaj.org/article/c1f1dcf2a27641a285019a0f13e129a2
Autor:
Tom G Richardson, Eleanor Sanderson, Tom M Palmer, Mika Ala-Korpela, Brian A Ference, George Davey Smith, Michael V Holmes
Publikováno v:
PLoS Medicine, Vol 17, Iss 3, p e1003062 (2020)
BackgroundCirculating lipoprotein lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. Using genetic instruments for lipoprotein lip
Externí odkaz:
https://doaj.org/article/05d52afa4ac34bb5ab25a2523cfcdd7a
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28834 (2011)
BackgroundWe sought to determine if a common polymorphism can influence vulnerability to LDL cholesterol, and thereby influence the clinical benefit derived from therapies that reduce LDL cholesterol.MethodsWe conducted a meta-analysis of the associa
Externí odkaz:
https://doaj.org/article/350a104c561d4a4ab589b1161eaf662a
Autor:
Gian Marco De Marchis, Tolga D. Dittrich, Rainer Malik, Annaelle V. Zietz, Lilian F. Kriemler, Brian A. Ference, Martin Dichgans, Marios K. Georgakis
Publikováno v:
Atherosclerosis. 361:41-46
Post hoc analyses of clinical trials show that PCSK9 inhibitors might lower lipoprotein(a), but whether this effect contributes to reductions in cardiovascular risk remains unknown. We aimed to assess whether genetically proxied PCSK9 inhibition infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f7e007c5503457b3fc1ca8e6b454fb
https://doi.org/10.1016/j.atherosclerosis.2022.09.007
https://doi.org/10.1016/j.atherosclerosis.2022.09.007
Autor:
Florian Kronenberg, Samia Mora, Erik S.G. Stroes, Brian A. Ference, Benoit J. Arsenault, Lars Berglund, Marc R. Dweck, Marlys L. Koschinsky, Gilles Lambert, François Mach, Catherine J. McNeal, Patrick M. Moriarty, Pradeep Natarajan, Børge G. Nordestgaard, Klaus G. Parhofer, Salim S. Virani, Arnold von Eckardstein, Gerald F. Watts, Jane K. Stock, Kausik K. Ray, Lale S. Tokgözoğlu, Alberico L. Catapano
Publikováno v:
Atherosclerosis.
In 2022, the European Atherosclerosis Society (EAS) published a new consensus statement on lipoprotein(a) [Lp(a)], summarizing current knowledge about its causal association with atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. One
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97114d6ec337c5b825384c71824a2709
https://doi.org/10.1016/j.atherosclerosis.2023.04.012
https://doi.org/10.1016/j.atherosclerosis.2023.04.012
Autor:
Brian A, Ference
Publikováno v:
Journal of the American College of Cardiology. 80:663-665
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362e2353ee6f67410a272a0a0ec133b7
https://doi.org/10.1016/j.jacc.2022.06.007
https://doi.org/10.1016/j.jacc.2022.06.007
Autor:
Zanfina Ademi, Jedidiah I. Morton, Danny Liew, Stephen J. Nicholls, Sophia Zoungas, Brian A. Ference
Funder: Monash University
Health economic analyses are essential for health services research, providing decision-makers and payers with evidence about the value of interventions relative to their opportunity cost. However, many health economic
Health economic analyses are essential for health services research, providing decision-makers and payers with evidence about the value of interventions relative to their opportunity cost. However, many health economic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe367853040bbabc6869fa7e06801bd
https://www.repository.cam.ac.uk/handle/1810/341873
https://www.repository.cam.ac.uk/handle/1810/341873
Autor:
Kausik K. Ray, Brian A. Ference, Tania Séverin, Dirk Blom, Stephen J. Nicholls, Mariko H. Shiba, Wael Almahmeed, Rodrigo Alonso, Magdalena Daccord, Marat Ezhov, Rosa Fernández Olmo, Piotr Jankowski, Fernando Lanas, Roopa Mehta, Raman Puri, Nathan D. Wong, David Wood, Dong Zhao, Samuel S. Gidding, Salim S. Virani, Donald Lloyd-Jones, Fausto Pinto, Pablo Perel, Raul D. Santos
Publikováno v:
Global Heart; Vol 17, No 1 (2022); 75
Global heart, vol 17, iss 1
Global heart, vol 17, iss 1
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a83d73740dfe497d75ee8356c39d2db
https://globalheartjournal.com/jms/article/view/1154
https://globalheartjournal.com/jms/article/view/1154
Autor:
Brian A. Ference, Radu Huculeci, Marie-Therese Cooney, Adam Timmis, Ian D. Graham, Panos Vardas, Dirk De Bacquer, Martin Halle, Frank L.J. Visseren, Emanuele Di Angelantonio
Publikováno v:
Journal of the American College of Cardiology. 77:3046-3057
Clinical estimation of the combined effect of several risk factors is unreliable and this resulted in the development of a number of risk estimation systems to guide clinical practice. Here, after defining general principles of risk estimation, the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::034d6426eef0ae21a053c3bb50197c22
https://doi.org/10.1016/j.jacc.2021.04.052
https://doi.org/10.1016/j.jacc.2021.04.052
Autor:
Gerald F. Watts, Brian A. Ference, Sophia Zoungas, Richard Norman, Zanfina Ademi, Albert Wiegman, Eric J.G. Sijbrands, Danny Liew, Jing Pang
Publikováno v:
Atherosclerosis, 304, 1-8. Elsevier Ireland Ltd
Background There are no studies that have specifically investigated the cost-effectiveness of cascade screening of children for heterozygous familial hypercholesterolemia (FH) and treatment of affected individuals with statins to prevent coronary hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640075c175ac2f372429fc3766ee0b7b
https://doi.org/10.1016/j.atherosclerosis.2020.05.007
https://doi.org/10.1016/j.atherosclerosis.2020.05.007